Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:acquiredBy |
gptkb:Astellas_Pharma
|
| gptkbp:acquisitionYear |
2019
|
| gptkbp:focusesOn |
immuno-oncology
gene therapy |
| gptkbp:foundedIn |
2016
|
| gptkbp:headquartersLocation |
gptkb:South_San_Francisco,_California,_United_States
|
| https://www.w3.org/2000/01/rdf-schema#label |
Xyphos Biosciences
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:platform |
ACCEL technology
|
| gptkbp:website |
https://www.xyphos.com/
|
| gptkbp:bfsParent |
gptkb:Astellas_Pharma_Inc.
|
| gptkbp:bfsLayer |
7
|